BioCubaFarma in the COVID-19 battle
To learn about progress being made in scientific research to identify new products to treat COVID-19, Granma interviews Dr. Eduardo Martínez Díaz, president of BioCubaFarma Enterprise Group
Author: Orfilio Peláez | informacion@granmai.cu
april 15, 2020 10:04:11

Photo: Ricardo López Hevia
To learn about progress being made in scientific research to identify new products to treat COVID-19, Granma interviews Dr. Eduardo Martínez Díaz, president of the BioCubaFarma Enterprise Group:
-What has the Cuban biotechnology and pharmaceutical industry been doing to confront COVID-19?
-Our Enterprise Group has a specific plan with four fundamental components which are
*Supply medicines included in the COVID-19treatment protocol established by the Ministry of Public Health (Minsap).
*Research and development to provide new products and knowledge to combat this virus
*Cooperation with other countries in supplying drugs to fight the pandemic
*Take steps internally within our companies to protect workers and guarantee operations under current circumstances
-How many products does BioCubaFarma currently provide for Cuba’s COVID-19 treatment protocol?
-At the beginning, 22 medicines were identified, several anti-virals, primarily Interferon, and an important group of drugs for hospital use with patients in different phases, including those in serious and critical condition. We currently have stocks of these for thousands of patients and continue to expand production capacity.
BioCubaFarma companies have added production of face masks and sanitizing products such as medicinal soaps, hypochlorite solution, hydroalcoholic solutions, etc. Continue reading BioCubaFarma in the COVID-19 battle →
You must be logged in to post a comment.